JP2024519078A5 - - Google Patents
Info
- Publication number
- JP2024519078A5 JP2024519078A5 JP2023571814A JP2023571814A JP2024519078A5 JP 2024519078 A5 JP2024519078 A5 JP 2024519078A5 JP 2023571814 A JP2023571814 A JP 2023571814A JP 2023571814 A JP2023571814 A JP 2023571814A JP 2024519078 A5 JP2024519078 A5 JP 2024519078A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- antibody
- binding fragment
- cea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021095113 | 2021-05-21 | ||
| CNPCT/CN2021/095113 | 2021-05-21 | ||
| CN2022088175 | 2022-04-21 | ||
| CNPCT/CN2022/088175 | 2022-04-21 | ||
| PCT/CN2022/093566 WO2022242681A1 (en) | 2021-05-21 | 2022-05-18 | Anti-cea antibodies and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519078A JP2024519078A (ja) | 2024-05-08 |
| JP2024519078A5 true JP2024519078A5 (https=) | 2025-05-22 |
Family
ID=84140248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571814A Pending JP2024519078A (ja) | 2021-05-21 | 2022-05-18 | 抗ｃｅａ抗体及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240190990A1 (https=) |
| EP (1) | EP4341299A4 (https=) |
| JP (1) | JP2024519078A (https=) |
| CN (1) | CN117396516A (https=) |
| TW (1) | TW202307004A (https=) |
| WO (1) | WO2022242681A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024165403A1 (en) * | 2023-02-06 | 2024-08-15 | Philogen S.P.A. | Anti-cea antibodies |
| WO2025242091A1 (zh) * | 2024-05-21 | 2025-11-27 | 康诺亚生物医药科技（成都）有限公司 | 针对ceacam5的抗体及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101528013B1 (ko) * | 2009-08-31 | 2015-06-16 | 로슈 글리카트 아게 | 친화성-성숙된 인간화된 항-ｃｅａ 단일클론 항체 |
| CN101928347B (zh) * | 2010-05-05 | 2013-03-27 | 上海海抗中医药科技发展有限公司 | 抗癌胚抗原抗体及其应用 |
| DK3199552T3 (da) * | 2012-11-20 | 2020-03-30 | Sanofi Sa | Anti-ceacam5-antistoffer og anvendelser heraf |
-
2022
- 2022-05-18 JP JP2023571814A patent/JP2024519078A/ja active Pending
- 2022-05-18 TW TW111118554A patent/TW202307004A/zh unknown
- 2022-05-18 WO PCT/CN2022/093566 patent/WO2022242681A1/en not_active Ceased
- 2022-05-18 EP EP22804001.0A patent/EP4341299A4/en active Pending
- 2022-05-18 CN CN202280036537.6A patent/CN117396516A/zh active Pending
-
2023
- 2023-11-17 US US18/513,255 patent/US20240190990A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024056938A5 (https=) | ||
| IL276830B1 (en) | Anti-claudin 18.2 antibodies and their uses | |
| JP2021524256A5 (https=) | ||
| JP2021514664A5 (https=) | ||
| JP2024522360A5 (https=) | ||
| JP2021534762A5 (https=) | ||
| CN117946277A (zh) | 多特异性抗体及其制备和使用方法 | |
| CN116948035A (zh) | 多特异性抗体及其制备和使用方法 | |
| CN113150156B (zh) | 抗tigit抗体及其用途 | |
| JP2023546743A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2017521054A5 (https=) | ||
| JP2022532991A5 (https=) | ||
| JP2021512652A5 (https=) | ||
| JP2023542209A5 (https=) | ||
| CN111712521A (zh) | Cd38蛋白抗体及其应用 | |
| JP2024521701A5 (https=) | ||
| JP2024519078A5 (https=) | ||
| JP2024522075A5 (https=) | ||
| JP2024533457A5 (https=) | ||
| IL321677A (en) | Anti-PDL1 antibodies, multispecific antibodies, and methods of use | |
| CN113549152B (zh) | 一种抗basigin人源化抗体及其应用 | |
| JP2024528987A5 (https=) | ||
| JP2024536358A5 (https=) |